Novanta Stock Forecast, Price & News

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Novanta in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" Novanta stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NOVT, but not buy additional shares or sell existing shares.
View analyst ratings for Novanta or view top-rated stocks.

Wall Street analysts have given Novanta a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Novanta wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Novanta is scheduled to release its next quarterly earnings announcement on Tuesday, August 10th 2021.
View our earnings forecast for Novanta.

Novanta will be holding an earnings conference call on Tuesday, August 10th at 10:00 AM Eastern. Interested parties can register for or listen to the call using this link.

Novanta Inc. (NASDAQ:NOVT) issued its quarterly earnings data on Tuesday, May, 11th. The technology company reported $0.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.39 by $0.19. The technology company had revenue of $162.60 million for the quarter, compared to the consensus estimate of $156.28 million. Novanta had a net margin of 7.34% and a trailing twelve-month return on equity of 15.66%. Novanta's revenue for the quarter was up 4.6% compared to the same quarter last year. During the same period last year, the business posted $0.51 EPS.
View Novanta's earnings history.

Novanta's stock was trading at $79.04 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, NOVT shares have increased by 76.9% and is now trading at $139.85.
View which stocks have been most impacted by COVID-19.

Novanta updated its FY 2021 earnings guidance on Tuesday, June, 8th. The company provided earnings per share (EPS) guidance of $2.040-2.190 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.110. The company issued revenue guidance of $645 million-655 million, compared to the consensus revenue estimate of $644.35 million.

1 Wall Street analysts have issued 12-month price objectives for Novanta's shares. Their forecasts range from $109.00 to $109.00. On average, they anticipate Novanta's stock price to reach $109.00 in the next year. This suggests that the stock has a possible downside of 22.1%.
View analysts' price targets for Novanta or view top-rated stocks among Wall Street analysts.

44 employees have rated Novanta CEO Matthijs Glastra on Glassdoor.com. Matthijs Glastra has an approval rating of 87% among Novanta's employees.

Some companies that are related to Novanta include CAE (CAE), QuantumScape (QS), EnerSys (ENS), Spectrum Brands (SPB), Atkore (ATKR), Stem (STEM), Integer (ITGR), Energizer (ENR), Security Devices International (SDEV), Eos Energy Enterprises (EOSE), Byrna Technologies (BYRN), Advent Technologies (ADN), CBAK Energy Technology (CBAT), Microvast (MVST) and Rodgers Silicon Valley Acquisition (RSVA).
View all of NOVT's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Novanta investors own include NVIDIA (NVDA), Alibaba Group (BABA), Gilead Sciences (GILD), Intuitive Surgical (ISRG), Lam Research (LRCX), Altria Group (MO), AT&T (T), Abiomed (ABMD), Advanced Micro Devices (AMD) and Broadcom (AVGO).

Novanta trades on the NASDAQ under the ticker symbol "NOVT."

Novanta's stock is owned by a variety of institutional and retail investors. Top institutional investors include Alliancebernstein L.P. (4.59%), Conestoga Capital Advisors LLC (3.16%), Ziegler Capital Management LLC (0.09%), Exchange Traded Concepts LLC (0.04%), Zurcher Kantonalbank Zurich Cantonalbank (0.01%) and Corbett Road Capital Management LLC (0.01%). Company insiders that own Novanta stock include Brian S Young, Matthijs Glastra, Peter L Chang, Robert Buckley and Stephen W Bershad.
View institutional ownership trends for Novanta.

NOVT stock was sold by a variety of institutional investors in the last quarter, including Ziegler Capital Management LLC, Corbett Road Capital Management LLC, and Zurcher Kantonalbank Zurich Cantonalbank . Company insiders that have sold Novanta company stock in the last year include Brian S Young, Matthijs Glastra, Peter L Chang, and Robert Buckley.
View insider buying and selling activity for Novanta or view top insider-selling stocks.

NOVT stock was bought by a variety of institutional investors in the last quarter, including Alliancebernstein L.P., Conestoga Capital Advisors LLC, Tuttle Tactical Management, Exchange Traded Concepts LLC, and Cooper Financial Group.
View insider buying and selling activity for Novanta or or view top insider-buying stocks.

Shares of NOVT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of NOVT stock can currently be purchased for approximately $139.85.

Novanta has a market capitalization of $4.95 billion and generates $590.62 million in revenue each year. The technology company earns $44.52 million in net income (profit) each year or $1.95 on an earnings per share basis.

Novanta employs 2,200 workers across the globe.

The official website for Novanta is www.novanta.com.

Novanta is headquartered at 125 Middlesex Turnpike, Bedford MA, 01730.

Novanta's mailing address is 125 Middlesex Turnpike, Bedford MA, 01730. The technology company can be reached via phone at (781) 266-5700 or via email at [email protected]